A review of global human infection with avian influenza and epidemiological characteristics
Hui JIANG,ShengJie LAI,Ying QIN,ZhiJie ZHANG,LuZhao FENG,HongJie YU
DOI: https://doi.org/10.1360/N972017-00267
2017-01-01
Chinese Science Bulletin
Abstract:Avian influenza virus is an influenza A virus, which generallyspreads among birds, without direct infection of human. Accordingto the pathogenicity to chicken or turkey, it is divided into high,medium and low/non pathogenic. When the virus gene recombination ormutation, it will get the ability to infect human. Additionally, avianinfluenza virus can also infect human directly, such as H5N1, H7N9,H5N6, H10N8 subtype. The cases of human infection with avian influenzareported frequently after the outbreak of human infection with H7N7avian influenza in 1959, the first death case due to avian influenzavirus infection causing respiratory disease was the outbreak of humaninfection with H5N1 in Hongkong in 1997. To date, human infectionwith avian influenza is a global public health problem. As avian influenzaviruses perpetuated in their natural hosts, with their high geneticdivergence, it would be precursor viruses even for pandemic potential.In the 20th century, four influenza pandemics were closely relatedto avian influenza viruses, avian is the natural host of the avianinfluenza virus, poultry carrying virus and dead/sick poultry infectedwith avian influenza virus are easier to spread virus to human, themain transmission routes are birds-human transmission (exposure tosick/dead poultry) and environment-human transmission (such as visitlive poultry market). Poultries exposure and chronic medical conditionare the main risk factors of human infection with avian influenza.The symptoms varies including ordinary influenza-like illness (ILI),conjunctivitis, arthritis, severe pneumonia, respiratory failure ,shock and death. At present, the treatment of human infection withavian influenza includes antiviral treatment, symptomatic treatment,Chinese medicine treatment, but the most important therapy of humaninfection with avian influenza is the treatment of antiviral drugs(neuraminidase inhibitors), using high dose antiviral drugs in theearly stage can significantly improve the survival rate. PCR and real-timePCR are the best methods for preliminary diagnosis of human infectionwith avian influenza. At the same time, the increase of serum antibodytiter in acute stage or recovery stage can alao be confirmed. In addition,effective preventive measures (such as publicity and education, behavioralintervention and vaccination development and application) are theimportant means to protect human from avian influenza.